A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants

Objective - To examine the impact of central nervous system (CNS) stimulants on the growth of children with attention-deficit/hyperactivity disorder (ADHD), and to assess the efficacy and feasibility of weight recovery interventions on growth. - Method - A total of 230 children aged 5 to 12 years wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Waxmonsky, James G. (VerfasserIn) , Babocsai, Lysett (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Journal of the American Academy of Child and Adolescent Psychiatry
Year: 2019, Jahrgang: 59, Heft: 12, Pages: 1330-1341
ISSN:1527-5418
DOI:10.1016/j.jaac.2019.08.472
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jaac.2019.08.472
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S089085671931929X
Volltext
Verfasserangaben:James G. Waxmonsky, MD, William E. Pelham, III, MA, Adriana Campa, PhD, Daniel A. Waschbusch, PhD, Tan Li, PhD, Rebecca Marshall, MS, Lysett Babocsai, PhD, Hugh Humphery, MD, Elizabeth Gnagy, MA, James Swanson, PhD, Negar Fallahazad, BS, William E. Pelham Jr, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1695558243
003 DE-627
005 20240405193242.0
007 cr uuu---uuuuu
008 200421r20202019xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jaac.2019.08.472  |2 doi 
035 |a (DE-627)1695558243 
035 |a (DE-599)KXP1695558243 
035 |a (OCoLC)1341316161 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Waxmonsky, James G.  |e VerfasserIn  |0 (DE-588)1208742779  |0 (DE-627)1695568206  |4 aut 
245 1 2 |a A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants  |c James G. Waxmonsky, MD, William E. Pelham, III, MA, Adriana Campa, PhD, Daniel A. Waschbusch, PhD, Tan Li, PhD, Rebecca Marshall, MS, Lysett Babocsai, PhD, Hugh Humphery, MD, Elizabeth Gnagy, MA, James Swanson, PhD, Negar Fallahazad, BS, William E. Pelham Jr, PhD 
264 1 |c 2020 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 29 August 2019 
500 |a Gesehen am 16.07.2021 
520 |a Objective - To examine the impact of central nervous system (CNS) stimulants on the growth of children with attention-deficit/hyperactivity disorder (ADHD), and to assess the efficacy and feasibility of weight recovery interventions on growth. - Method - A total of 230 children aged 5 to 12 years with ADHD with no history of chronic CNS stimulant use were randomly assigned to receive daily CNS stimulants (78%, primarily OROS-methylphenidate [OROS-MPH]) or behavioral treatment (22%) for 30 months. After 6 months, children evidencing a decline in body mass index (BMI) of >0.5 z-units were randomized to 1 of 3 weight recovery treatments (WRTs): monthly monitoring of height/weight (MON) plus continued daily medication; drug holidays (DH) with medication limited to school days; or daily caloric supplementation (CS) with a 150-kcal supplement plus daily medication. - Results - Before WRT assignment, medication was associated with significant reductions in standardized weight and height (p values <.01). Adherence to CS and DH during WRT was high, with significant increases in daily caloric intake and decreases in weekly medication exposure (p values <.05). Across all WRT participants (n = 71), weight velocity increased significantly after WRT randomization (β2 = 0.271, SE = 0.027, p < .001).When analyzed by what parents did (versus what they were assigned to), CS (p < .01) and DH (p < .05) increased weight velocity more than MON. No increase in height velocity was seen after randomization to any WRT. Over the entire study, WRT participants declined in standardized weight (−0.44 z-units) and height (−0.20 z-units). - Conclusion - Drug holidays, caloric supplementation, and increased monitoring all led to increased weight velocity in children taking CNS stimulants, but none led to increased height velocity. - Clinical trial registration information - Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth; https://clinicaltrials.gov/; NCT01109849. 
534 |c 2019 
650 4 |a attention-deficit/hyperactivity disorder 
650 4 |a CNS stimulants 
650 4 |a growth 
700 1 |a Babocsai, Lysett  |e VerfasserIn  |0 (DE-588)137342314  |0 (DE-627)592108228  |0 (DE-576)303195584  |4 aut 
773 0 8 |i Enthalten in  |a American Academy of Child and Adolescent Psychiatry  |t Journal of the American Academy of Child and Adolescent Psychiatry  |d Kidlington [u.a.] : Elsevier, 1987  |g 59(2020), 12, Seite 1330-1341  |h Online-Ressource  |w (DE-627)32061638X  |w (DE-600)2022051-0  |w (DE-576)094402027  |x 1527-5418  |7 nnas 
773 1 8 |g volume:59  |g year:2020  |g number:12  |g pages:1330-1341  |g extent:12  |a A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants 
856 4 0 |u https://doi.org/10.1016/j.jaac.2019.08.472  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S089085671931929X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200421 
993 |a Article 
994 |a 2020 
998 |g 137342314  |a Babocsai, Lysett  |m 137342314:Babocsai, Lysett  |d 100000  |d 100200  |e 100000PB137342314  |e 100200PB137342314  |k 0/100000/  |k 1/100000/100200/  |p 7 
999 |a KXP-PPN1695558243  |e 3628573866 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"12 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Kidlington [u.a.] ; Philadelphia, Pa. [u.a.]","dateIssuedKey":"1987","publisher":"Elsevier ; Lippincott, Williams & Wilkins","dateIssuedDisp":"1987-"}],"id":{"issn":["1527-5418"],"zdb":["2022051-0"],"eki":["32061638X"]},"pubHistory":["26.1987 -"],"titleAlt":[{"title":"JAACAP"}],"part":{"issue":"12","pages":"1330-1341","year":"2020","extent":"12","text":"59(2020), 12, Seite 1330-1341","volume":"59"},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"American Academy of Child and Adolescent PsychiatryJournal of the American Academy of Child and Adolescent Psychiatry","note":["Gesehen am 15.01.20"],"recId":"32061638X","corporate":[{"role":"aut","roleDisplay":"VerfasserIn","display":"American Academy of Child and Adolescent Psychiatry"}],"language":["eng"],"title":[{"title_sort":"Journal of the American Academy of Child and Adolescent Psychiatry","subtitle":"JAACAP","title":"Journal of the American Academy of Child and Adolescent Psychiatry"}]}],"name":{"displayForm":["James G. Waxmonsky, MD, William E. Pelham, III, MA, Adriana Campa, PhD, Daniel A. Waschbusch, PhD, Tan Li, PhD, Rebecca Marshall, MS, Lysett Babocsai, PhD, Hugh Humphery, MD, Elizabeth Gnagy, MA, James Swanson, PhD, Negar Fallahazad, BS, William E. Pelham Jr, PhD"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"2020"}],"id":{"eki":["1695558243"],"doi":["10.1016/j.jaac.2019.08.472"]},"note":["Available online 29 August 2019","Gesehen am 16.07.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1695558243","person":[{"family":"Waxmonsky","given":"James G.","display":"Waxmonsky, James G.","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Babocsai, Lysett","role":"aut","family":"Babocsai","given":"Lysett"}],"title":[{"title":"A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants","title_sort":"randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants"}]} 
SRT |a WAXMONSKYJRANDOMIZED2020